Sue Washer | Chief Executive Officer |
Matt Feinsod | Chief Medical Officer |
Bill Sullivan | Chief Financial Officer |
Matthew Luchini | BMO Capital Markets |
Joe Pantginis | H.C. Wainwright |
David Nierengarten | Wedbush Securities |
Yanan Zhu | Wells Fargo |
Good morning, and welcome to the AGTC Third Quarter Fiscal Year 2019 Financial Results Conference Call. Today’s call is being recorded.
Before we get started, I’d like to remind everyone that during the conference call, AGTC may make forward-looking statement, including statements about the company’s financial results, financial guidance, its future business strategies and operations and its product development and regulatory progress. Actual results could differ materially from those discussed in these forward-looking statements due to a number of important risk factors, including uncertainty inherent in the clinical development and regulatory process and other risks described in the Risk Factors section of AGTC’s annual report on Form 10-K for the fiscal year ended June 30, 2018, and quarterly reports on Form 10-Q for subsequent periods.
For introductions and opening remarks, I’d like to turn the call over to Sue Washer, Chief Executive Officer of AGTC.